[Skip to Navigation]
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue
JAMA Network Home
JAMA Internal Medicine
Sign In
New Online Current Issue Past Issues
JAMA Network Statement on Potentially Offensive Content

April 2023 - January 1908

Decade

Year

Issue

May 28, 2012, Vol 172, No. 10, Pages 756-823

Editorial

ONLINE FIRST

What Does Off-label Prescribing Really Mean?

Patrick G. O’Malley, MD, MPH
Abstract Full Text
Arch Intern Med. 2012;172(10):759-760. doi:10.1001/archinternmed.2012.789
Original Investigation

Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality

Tinh-Hai Collet, MD; Jacobijn Gussekloo, MD, PhD; Douglas C. Bauer, MD; et al.
Abstract Full Text
free access has audio
Arch Intern Med. 2012;172(10):799-809. doi:10.1001/archinternmed.2012.402
  • Audio Author Interview: Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality and Kenneth D. Burman, MD, author of What Is the Clinical Importance of Subclinical Hyperthyroidism?

ONLINE FIRST

A Randomized Controlled Trial of Telemonitoring in Older Adults With Multiple Health Issues to Prevent Hospitalizations and Emergency Department Visits

Paul Y. Takahashi, MD, MPH; Jennifer L. Pecina, MD; Benjavan Upatising, MSIE, PhD; et al.
Abstract Full Text
free access
Arch Intern Med. 2012;172(10):773-779. doi:10.1001/archinternmed.2012.256

ONLINE FIRST

Drug, Patient, and Physician Characteristics Associated With Off-label Prescribing in Primary Care

Tewodros Eguale, MD, MSc; David L. Buckeridge, MD, PhD; Nancy E. Winslade, PharmD; et al.
Abstract Full Text
free access
Arch Intern Med. 2012;172(10):781-788. doi:10.1001/archinternmed.2012.340

Multiple Behavior Changes in Diet and Activity: A Randomized Controlled Trial Using Mobile Technology

Bonnie Spring, PhD; Kristin Schneider, PhD; H. Gene McFadden, BS; et al.
Abstract Full Text
free access
Arch Intern Med. 2012;172(10):789-796. doi:10.1001/archinternmed.2012.1044

Levothyroxine Treatment of Subclinical Hypothyroidism, Fatal and Nonfatal Cardiovascular Events, and Mortality

Salman Razvi, MD, FRCP; Jolanta U. Weaver, PhD, FRCP; Timothy J. Butler, MRCGP; et al.
Abstract Full Text
free access
Arch Intern Med. 2012;172(10):811-817. doi:10.1001/archinternmed.2012.1159
Invited Commentary

Understanding the Long-term Benefits and Dangers of Intensive Therapy of Diabetes: Comment on “Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus”

David M. Nathan, MD
Abstract Full Text
Arch Intern Med. 2012;172(10):769-770. doi:10.1001/archinternmed.2012.438

Prioritizing Treatments in Type 2 Diabetes Mellitus: Comment on “Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus”

Karen L. Margolis, MD, MPH; Patrick J. O’Connor, MD, MA, MPH
Abstract Full Text
Arch Intern Med. 2012;172(10):770-772. doi:10.1001/archinternmed.2012.1775

ONLINE FIRST

Another Sobering Result for Home Telehealth—and Where We Might Go Next: Comment on “A Randomized Controlled Trial of Telemonitoring in Older Adults With Multiple Health Issues to Prevent Hospitalizations and Emergency Department Visits”

Scott R. Wilson, DO; Peter Cram, MD, MBA
Abstract Full Text
Arch Intern Med. 2012;172(10):779-780. doi:10.1001/archinternmed.2012.685

Leveraging Technology for Multiple Risk Factor Interventions : Comment on “Multiple Behavior Changes in Diet and Activity”

William T. Riley, PhD
Abstract Full Text
Arch Intern Med. 2012;172(10):796-798. doi:10.1001/archinternmed.2012.1633

What Is the Clinical Importance of Subclinical Hyperthyroidism?Comment on “Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality”

Kenneth D. Burman, MD
Abstract Full Text
Arch Intern Med. 2012;172(10):809-810. doi:10.1001/archinternmed.2012.1114
Review

Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis

Steven G. Coca, DO, MS; Faramarz Ismail-Beigi, MD, PhD; Nowreen Haq, MD, MPH; et al.
Abstract Full Text
free access
Arch Intern Med. 2012;172(10):761-769. doi:10.1001/archinternmed.2011.2230
Research Letter

Health Care as a “Market Good”? Appendicitis as a Case Study

Renee Y. Hsia, MD, MSc; Abbas H. Kothari, BA; Tanja Srebotnjak, PhD; et al.
Abstract Full Text
free access
Arch Intern Med. 2012;172(10):818-819. doi:10.1001/archinternmed.2012.1173

Effect of Physician Payment Disclosure Laws on Prescribing

Genevieve Pham-Kanter, PhD; G. Caleb Alexander, MD, MS; Kavita Nair, PhD
Abstract Full Text
free access
Arch Intern Med. 2012;172(10):819-821. doi:10.1001/archinternmed.2012.1210

Characteristics of “Complex” Patients With Type 2 Diabetes Mellitus According to Their Primary Care Physicians

Richard W. Grant, MD, MPH; Deborah J. Wexler, MD, MSc; Jeffrey M. Ashburner, MPH; et al.
Abstract Full Text
free access
Arch Intern Med. 2012;172(10):821-823. doi:10.1001/archinternmed.2012.1229
Images From Our Readers

FDR Drive

Abstract Full Text
Arch Intern Med. 2012;172(10):772. doi:10.1001/archinternmed.2012.1204
Editor's Correspondence

Fecal Transplant for Clostridium difficile

Neil Stollman, MD; Christina Surawicz, MD
Abstract Full Text
Arch Intern Med. 2012;172(10):825-826. doi:10.1001/archinternmed.2012.1055

Dabigatran and Myocardial Infarction: Meta-Illusion?—Reply

Ken Uchino, MD; Adrian V. Hernandez, MD, PhD
Abstract Full Text
Arch Intern Med. 2012;172(10):823-823. doi:10.1001/archinternmed.2012.1154

A Role for Opioids in Chronic Pain Management—Reply

Deborah Grady, MD, MPH; Mitchell H. Katz, MD; Seth A. Berkowitz, MD
Abstract Full Text
Arch Intern Med. 2012;172(10):824-825. doi:10.1001/archinternmed.2012.1340

Fecal Transplant for Clostridium difficile—Reply

Zain Kassam, MD; John Marshall, MD, FRCPC; Christine H. Lee, MD, FRCPC, FIDSA
Abstract Full Text
Arch Intern Med. 2012;172(10):825-826. doi:10.1001/archinternmed.2012.1413

Dabigatran and Myocardial Infarction: Meta-Illusion?

Luis C. L. Correia, MD, PhD; Antonio A. Lopes, MD, MPH, PhD
Abstract Full Text
Arch Intern Med. 2012;172(10):823-823. doi:10.1001/archinternmed.2012.836

A Role for Opioids in Chronic Pain Management

Bill  McCarberg, MD; Kathryn L. Hahn, PharmD, CPE, DAAPM; Robert K. Twillman, PhD; et al.
Abstract Full Text
Arch Intern Med. 2012;172(10):824-825. doi:10.1001/archinternmed.2012.882
In This Issue of Archives of Internal Medicine

In This Issue of Archives of Internal Medicine

Abstract Full Text
free access
Arch Intern Med. 2012;172(10):757. doi:10.1001/archinternmed.2011.947
Most Viewed(30 Days) RSS link
Most Cited(3 Years) RSS Link
View more
View more
×
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Sign in to access free PDF
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Save your search
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Make a comment
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
  • Register for email alerts with links to free full-text articles
  • Access PDFs of free articles
  • Manage your interests
  • Save searches and receive search alerts
Privacy Policy